Sponsored by: Fujifilm

MRI: Page 481

Fonar releases 2007 year-end results
By AuntMinnie.com staff writers
Revenues for MRI vendor Fonar stayed relatively flat in the company's fiscal year 2007 (end-June 30).
September 30, 2007
InSightec proceeds with phase I trial
By AuntMinnie.com staff writers
Focused-ultrasound developer InSightec has begun the second stage of a phase I clinical trial for noninvasive treatment of brain tumors using MR-guided focused ultrasound (MRgFUS) surgery on the Haifa, Israel-based company's ExAblate system.
September 25, 2007
ONI makes exec moves
Extremity MRI developer ONI Medical Systems of Wilmington, MA, has announced several new executive appointments.
September 24, 2007
How good is breast MRI? Also, breast cancer rates fall again
By Brian Casey
September 24, 2007
Does MRI help in treatment of second breast cancers? Don't be too sure
By Kate Madden Yee
Given breast MRI's impressive sensitivity, a natural assumption might be that MR results would improve outcomes and lead to more on-target cancer treatment planning. But the data just aren't there yet for breast MR to be used routinely in the staging and screening of second breast cancers, according to breast surgeon Dr. Kimberly Van Zee, who expressed her reservations about breast MR at the American Society of Clinical Oncology's 2007 Breast Cancer Symposium.
September 24, 2007
2007 09 24 14 55 04 706
MR-guided breast biopsy results need careful correlation with histology for on-time diagnosis
By Shalmali Pal
Concordance between imaging results and histology results after biopsy is essential to avoid a breast cancer diagnosis delay. Investigators from Memorial-Sloan Kettering Cancer Center in New York City looked at the rate of imaging-histologic discordance on MRI-guided biopsy, and found that while mismatches frequently were significant, they can be reduced through careful planning.
September 23, 2007
2007 09 21 15 16 00 706
Combining T2-weighted MRI and DWI improves prostate cancer detection
By Radiology Review
(Radiology Review) Combined T2-weighted MRI and diffusion-weighted imaging (DWI) is significantly better than T2-weighted imaging alone for detecting peripheral zone prostate cancer, according to a report in the August issue of American Journal of Roentgenology.
September 20, 2007
Aurora lands first NJ install
By AuntMinnie.com staff writers
Breast MRI developer Aurora Imaging Technology of North Andover, MA, has made the first installation of its 1.5-tesla breast scanner in New Jersey.
September 18, 2007
Medrad broadens eCoil availability
By AuntMinnie.com staff writers
Contrast injector firm Medrad said that its 3-tesla prostate eCoil MR endorectal coil is now compatible with MR scanners from Philips Medical Systems and Siemens Medical Solutions.
September 18, 2007
Aurora society forms China partnership
By AuntMinnie.com staff writers
Breast MRI advocacy group Aurora Breast MRI Society (ABMS) is collaborating with the China Medical Women's Association on a professional exchange program.
September 17, 2007
MR experts take issue with FDA gadolinium warning
By Shalmali Pal
In May 2007, the U.S. Food and Drug Administration (FDA) recommend that a "black box" warning label be places on all gadolinium-based contrast agents. Now a group of MR safety experts have deemed the FDA's suggestion as "imprudent." They argue that the risk of a patient with renal disease developing nephrogenic systemic fibrosis (NSF) does not currently appear to be the same among the various gadolinium-based MR contrast agents.
September 17, 2007
Neurognostics adds clients
By AuntMinnie.com staff writers
Functional MRI (fMRI) developer Neurognostics has inked a deal to provide its fMRI system to the Cleveland Clinic and the University of Iowa in Iowa City.
September 16, 2007
Previous Page
Page 481 of 624
Next Page